SCHEMBL11956407

SCHEMBL11956407

CC[C@@H](CO)n1cc(C=O)c(=O)c2cc(I)c(F)cc21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11956094 0.85 KMT2A (0.31) —
SCHEMBL13472096 0.84 METTL3 (0.37) —
SCHEMBL13250853 0.84 METTL3 (0.37) —
SCHEMBL11956472 0.84 METTL3 (0.37) —
SCHEMBL11956473 0.83 — —
SCHEMBL16850594 0.78 KMT2A (0.49) —
SCHEMBL11948596 0.78 KMT2A (0.49) —
SCHEMBL13862193 0.77 METTL3 (0.47) —
SCHEMBL12961416 0.76 — —
SCHEMBL13862218 0.76 METTL3 (0.48) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8232401-B2 Useful as an anti-HIV agent that particularly shows an anti-HIV action based on an integrase inhibitory activity; for treatment or prophylaxis of AIDS; for example, 6-(2,3-dichlorobenzyl)-1-(2-hydroxyethyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid JAPAN TOBACCO INC. (JP) 2012-07-31 — — US disclosed
US-7531554-B2 Useful as an anti-HIV agent that particularly shows an anti-HIV action based on an integrase inhibitory activity; for treatment or prophylaxis of AIDS; for example, 6-(2,3-dichlorobenzyl)-1-(2-hydroxyethyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid JAPAN TOBACCO INC. (JP) 2009-05-12 — — US disclosed
Send feedback